The purpose of this study is to characterize CD86 receptor occupancy in subjects with rheumatoid arthritis (RA) receiving abatacept.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01339481?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
The purpose of this study is to characterize CD86 receptor occupancy in subjects with rheumatoid arthritis (RA) receiving abatacept.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01339481?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
Improving orthopaedic care, education and research using Internet technologies